Vertigo, a complex clinical symptom often encountered in healthcare practice, is characterized by an illusion of movement, typically rotational in nature. Understanding its pathophysiology, diagnostic methods, and treatment strategies is crucial for healthcare professionals to provide optimal patient care.
Vertigo is primarily a vestibular system disorder, with causes ranging from benign paroxysmal positional vertigo (BPPV) to more serious conditions like Meniere's disease or vestibular neuritis. It can also be a secondary symptom of neurological disorders such as stroke or multiple sclerosis. It's essential to distinguish vertigo from other forms of dizziness, as the management strategies differ significantly.
Diagnosis of vertigo involves a detailed patient history, physical examination, and, when necessary, specific diagnostic tests. The Dix-Hallpike maneuver is a standard test for BPPV, while caloric testing and vestibular evoked myogenic potentials (VEMP) can help diagnose other vestibular disorders. Neuroimaging may be required if central causes are suspected.
Management of vertigo is multifaceted, involving symptomatic treatment, physical therapy, and addressing the underlying cause. Medications such as meclizine and diazepam can provide symptomatic relief. Canalith repositioning maneuvers are effective for BPPV, while vestibular rehabilitation therapy can help in chronic vertigo. In refractory cases, surgical interventions may be considered.
A comprehensive understanding of vertigo is imperative for accurate diagnosis and effective management. By staying abreast of the latest research and utilizing a systematic clinical approach, healthcare professionals can significantly improve the quality of life for patients suffering from this debilitating symptom.
1.
Chemo-Free Triplet Yields 68% Response Rate in Richter Transformation
2.
Can Fasting Around Chemo Improve Ovarian Cancer Outcomes?
3.
Chemo causes lasting physical decline in breast cancer survivors
4.
MRI-guided radiation therapy improves quality of life with fewer side effects in patients with localized cancer. JAMA
5.
BMI is linked to heart damage from chemotherapy in breast cancer patients.
1.
The Role of the Oncology Pharmacist: From Treatment to Trials and Beyond
2.
Rehabilitation Following Bone Marrow Functional Suppression: Clinical Strategies and Advances
3.
Unlocking the Potential of Cancer Antigen 19-9 for Early Detection
4.
Strategic Breakthroughs in Oncology in Clinical Decision-Making
5.
Targeted Approaches to Breast Cancer Liver Metastases: Surgery, Ablation, and Survival Insights
1.
International Conference on Innovations in Critical Care for Oncology and Cardiology
2.
International Conference on Oncology, Cardiology and Critical Care Policy
3.
International Conference on Oncology, Cancer Prevention and Public Health
4.
International Conference on Cancer Nursing and Rehabilitation Strategies
5.
International Conference on Best Practices in Oncology, Cardiology and Critical Care
1.
Efficient Management of First line ALK-rearranged NSCLC - Part VI
2.
Early warning sings of camcer that need medical attention
3.
A Comprehensive Guide to First Line Management of ALK Positive Lung Cancer - Part I
4.
The Landscape of First-Line Treatment for Urothelial Carcinoma- Further Discussion
5.
Unmet Needs in ALK Positive NSCLC- The Challenges in the Current Care
© Copyright 2026 Hidoc Dr. Inc.
Terms & Conditions - LLP | Inc. | Privacy Policy - LLP | Inc. | Account Deactivation